Interferon beta-1a

Rebif (interferon beta-1a) is a prescription medication manufactured by EMD Serono, Inc., used to treat relapsing forms of multiple sclerosis (MS). It comes in prefilled syringes for subcutaneous injection in strengths of 22 mcg/0.5 mL and 44 mcg/0.5 mL. Approved in 2002 under BLA103780, it belongs to the interferon beta class of drugs. This information was generated using AI and is provided for informational and research purposes only.